Tango Therapeutics, Inc. - Common Stock (TNGX)
CUSIP: 87583X109
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 135,353,744
- Total 13F shares
- 67,775,150
- Share change
- +2,309,802
- Total reported value
- $740,996,532
- Price per share
- $10.94
- Number of holders
- 57
- Value change
- +$24,899,642
- Number of buys
- 31
- Number of sells
- 14
Quarterly Holders Quick Answers
What is CUSIP 87583X109?
CUSIP 87583X109 identifies TNGX - Tango Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87583X109:
Top shareholders of TNGX - Tango Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| TRV GP IV, LLC |
13F
|
Company |
14%
|
19,363,975
|
$250,376,000 | — | 30 Sep 2021 | |
| Boxer Capital, LLC |
13F
|
Company |
5.1%
|
6,871,642
|
$88,850,000 | — | 30 Sep 2021 | |
| FMR LLC |
13F
|
Company |
4.6%
|
6,251,913
|
$80,838,000 | — | 30 Sep 2021 | |
| Casdin Capital, LLC |
13F
|
Company |
4.1%
|
5,487,910
|
$70,959,000 | — | 30 Sep 2021 | |
| BCTG Holdings, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,988,450
|
$58,642,879 | — | 10 Aug 2021 | |
| HHLR ADVISORS, LTD. |
13F
|
Company |
3.2%
|
4,373,982
|
$56,556,000 | — | 30 Sep 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2.9%
|
3,899,185
|
$48,814,000 | — | 30 Sep 2021 | |
| Southpoint Capital Advisors LP |
13F
|
Company |
2.2%
|
3,000,000
|
$38,790,000 | — | 30 Sep 2021 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.7%
|
2,250,000
|
$29,093,000 | — | 30 Sep 2021 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
1.4%
|
1,921,790
|
$24,849,000 | — | 30 Sep 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
1.1%
|
1,550,000
|
$20,042,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
1,393,168
|
$18,014,000 | — | 30 Sep 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
1,384,826
|
$17,906,000 | — | 30 Sep 2021 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.96%
|
1,300,000
|
$16,809,000 | — | 30 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.55%
|
750,000
|
$9,698,000 | — | 30 Sep 2021 | |
| HARVARD MANAGEMENT CO INC |
13F
|
Company |
0.52%
|
708,385
|
$9,159,000 | — | 30 Sep 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.52%
|
700,000
|
$9,051,000 | — | 30 Sep 2021 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.44%
|
600,000
|
$7,758,000 | — | 30 Sep 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.37%
|
500,040
|
$6,466,000 | — | 30 Sep 2021 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.35%
|
468,750
|
$6,061,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
428,635
|
$5,542,000 | — | 30 Sep 2021 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.31%
|
424,638
|
$5,491,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
408,525
|
$5,278,000 | — | 30 Sep 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
0.22%
|
300,000
|
$3,879,000 | — | 30 Sep 2021 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.22%
|
300,000
|
$3,879,000 | — | 30 Sep 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
198,100
|
$2,561,000 | — | 30 Sep 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.08%
|
113,150
|
$1,463,000 | — | 30 Sep 2021 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.07%
|
100,000
|
$1,293,000 | — | 30 Sep 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.06%
|
84,762
|
$1,096,000 | — | 30 Sep 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.04%
|
53,500
|
$692,000 | — | 30 Sep 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.04%
|
50,000
|
$647,000 | — | 30 Sep 2021 | |
| Walleye Capital LLC |
13F
|
Company |
0.03%
|
41,415
|
$535,000 | — | 30 Sep 2021 | |
| Janney Montgomery Scott LLC |
13F
|
Company |
0.03%
|
40,000
|
$517,000 | — | 30 Sep 2021 | |
| Aviva Holdings Ltd. |
13F
|
Company |
0.02%
|
26,961
|
$349,000 | — | 30 Sep 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
25,221
|
$326,000 | — | 30 Sep 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
24,311
|
$315,000 | — | 30 Sep 2021 | |
| Braslyn Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
26,961
|
$226,241 | — | 10 Aug 2021 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.01%
|
15,792
|
$204,000 | — | 30 Sep 2021 | |
| Walleye Trading LLC |
13F
|
Company |
0.01%
|
13,805
|
$178,000 | — | 30 Sep 2021 | |
| Old Well Partners, LLC |
13F
|
Company |
0.01%
|
11,554
|
$149,000 | — | 30 Sep 2021 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
11,022
|
$143,000 | — | 30 Sep 2021 | |
| Penserra Capital Management LLC |
13F
|
Company |
0.01%
|
10,344
|
$133,000 | — | 30 Sep 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,169
|
$41,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,847
|
$24,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,812
|
$23,000 | — | 30 Sep 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
828
|
$11,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
391
|
$5,000 | — | 30 Sep 2021 | |
| Marc Rudoltz |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
350,000
|
— | — | 01 Nov 2021 |
Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q4 2021
As of 31 Dec 2021,
Tango Therapeutics, Inc. - Common Stock (TNGX) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,775,150 shares.
The largest 10 holders included
TRV GP IV, LLC, FMR LLC, BOXER CAPITAL, LLC, Casdin Capital, LLC, Cormorant Asset Management, LP, HHLR ADVISORS, LTD., Southpoint Capital Advisors LP, RA CAPITAL MANAGEMENT, L.P., Bain Capital Life Sciences Investors, LLC, and Avoro Capital Advisors LLC.
This page lists
57
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
45
Q4 2021 holders
57
Holder diff
12
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.